Annemie Ribbens

Learn More
Healthy ageing coincides with a progressive decline of brain gray matter (GM) ultimately affecting the entire brain. For a long time, manual delineation-based volumetry within predefined regions of interest (ROI) has been the gold standard for assessing such degeneration. Voxel-Based Morphometry (VBM) offers an automated alternative approach that, however,(More)
The location and extent of white matter lesions on magnetic resonance imaging (MRI) are important criteria for diagnosis, follow-up and prognosis of multiple sclerosis (MS). Clinical trials have shown that quantitative values, such as lesion volumes, are meaningful in MS prognosis. Manual lesion delineation for the segmentation of lesions is, however,(More)
PURPOSE To validate the reproducibility of a chemical shift imaging (CSI) acquisition protocol with parallel imaging, using automated repositioning software. MATERIALS AND METHODS Ten volunteers were imaged three times on two different 3 Tesla (T) MRI scanners, receiving anatomical imaging and two identical CSI measurements, using automated repositioning(More)
Population analysis of brain morphology from magnetic resonance images contributes to the study and understanding of neurological diseases. Such analysis typically involves segmentation of a large set of images and comparisons of these segmentations between relevant subgroups of images (e.g., "normal" versus "diseased"). The images of each subgroup are(More)
Automated methods for image segmentation, image registration, clustering of images and probabilistic atlas construction are of great interest in medical image analysis. In this work, we propose a model where these different aspects are combined in one comprehensive probabilistic framework. The framework is formulated as an EM optimization algorithm.(More)
INTRODUCTION As neurodegeneration is recognized as a major contributor to disability in multiple sclerosis (MS), brain atrophy quantification could have a high added value in clinical practice to assess treatment efficacy and disease progression, provided that it has a sufficiently low measurement error to draw meaningful conclusions for an individual(More)
  • 1